Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study
2014
118 citations
Journal Article
Field-Weighted Citation Impact:
13.84
·
Mercy Medical Center
H. Tatum
Imam Waked
Gamal Esmat
·
Cairo University
Eric Lawitz
·
The University of Texas Health Science Center at San Antonio
Vinod K. Rustgi
Stanislas Pol
·
Inserm
Nina Weis
·
Copenhagen University Hospital
Paul J. Pockros
·
Scripps Clinic
Marc Bourlière
·
Hôpital Saint Joseph
Lawrence Serfaty
·
Sorbonne Université
John M. Vierling
·
Baylor College of Medicine
Michael Fried
·
University of North Carolina at Chapel Hill
Ola Weiland
·
Karolinska University Hospital
Maurizia Rossana Brunetto
·
Azienda Ospedaliera Universitaria Pisana
Gregory T. Everson
·
University of Colorado Denver
Stefan Zeuzem
·
Goethe University Frankfurt
Paul Y. Kwo
·
Indiana University – Purdue University Indianapolis
Mark Sulkowski
·
Johns Hopkins University
Norbert Bräu
·
James J. Peters VA Medical Center
Dennis Hernandez
·
Bristol-Myers Squibb (United States)
Fiona McPhee
·
Bristol-Myers Squibb (United States)
Megan Wind‐Rotolo
·
Bristol-Myers Squibb (United States)
Zhaohui Liu
·
Bristol-Myers Squibb (United States)
Stephanie Noviello
·
Bristol-Myers Squibb (United States)
Eric Hughes
·
Bristol-Myers Squibb (United States)
Philip D. Yin
·
Bristol-Myers Squibb (United States)
Steven Schnittman
·
Bristol-Myers Squibb (United States)
Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study | Researchclopedia